BIOGEN INC. Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Gain (Loss) Included in Earnings
BIOGEN INC. (BIIB) reported Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Gain (Loss) Included in Earnings of $20.50 million for the 3-month period ending 2026-03-31, per its 10-Q filed 2026-04-29.
Financial Statements › Income Statement › Other Income
us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings · last filed 2026-04-29
- BIOGEN INC. fair value, measurement with unobservable inputs reconciliation, recurring basis, liability, gain (loss) included in earnings for the quarter ending 2026-03-31 was $20.50M, a 113.54% increase year-over-year.
- BIOGEN INC. fair value, measurement with unobservable inputs reconciliation, recurring basis, liability, gain (loss) included in earnings for the quarter ending 2025-12-31 was -$62.00M.
- BIOGEN INC. fair value, measurement with unobservable inputs reconciliation, recurring basis, liability, gain (loss) included in earnings for the quarter ending 2025-09-30 was $5.60M, a 76.47% decline year-over-year.
- BIOGEN INC. fair value, measurement with unobservable inputs reconciliation, recurring basis, liability, gain (loss) included in earnings for the quarter ending 2025-06-30 was $13.20M.
- BIOGEN INC. fair value, measurement with unobservable inputs reconciliation, recurring basis, liability, gain (loss) included in earnings for fiscal 2025 was -$33.60M.
- BIOGEN INC. fair value, measurement with unobservable inputs reconciliation, recurring basis, liability, gain (loss) included in earnings for fiscal 2024 was -$27.70M.
- BIOGEN INC. fair value, measurement with unobservable inputs reconciliation, recurring basis, liability, gain (loss) included in earnings for fiscal 2023 was $0.00, a 100.00% decline from fiscal 2022.
- BIOGEN INC. fair value, measurement with unobservable inputs reconciliation, recurring basis, liability, gain (loss) included in earnings for fiscal 2022 was $209.10M, a 312.43% increase from fiscal 2021.
| Period end | Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Gain (Loss) Included in Earnings 3 month | Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Gain (Loss) Included in Earnings 3 month as first filed | Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Gain (Loss) Included in Earnings 6 month | Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Gain (Loss) Included in Earnings 6 month as first filed | Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Gain (Loss) Included in Earnings 9 month | Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Gain (Loss) Included in Earnings 9 month as first filed | Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Gain (Loss) Included in Earnings 12 month | Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Gain (Loss) Included in Earnings 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-03-31 | $20.50M 10-Q · filed 2026-04-29 | -$41.50M derived: sum of 2 quarters · filed 2026-04-29 | -$35.90M derived: sum of 3 quarters · filed 2026-04-29 | -$22.70M derived: sum of 4 quarters · filed 2026-04-29 | ||||
| 2025-12-31 | -$62.00M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-06 | -$56.40M derived: sum of 2 quarters · filed 2026-02-06 | -$43.20M derived: sum of 3 quarters · filed 2026-02-06 | -$33.60M 10-K · filed 2026-02-06 | ||||
| 2025-09-30 | $5.60M 10-Q · filed 2025-10-30 | $18.80M derived: sum of 2 quarters · filed 2025-10-30 | $28.40M 10-Q · filed 2025-10-30 | -$23.10M derived: sum of 4 quarters · filed 2026-04-29 | ||||
| 2025-06-30 | $13.20M 10-Q · filed 2025-07-31 | $22.80M 10-Q · filed 2025-07-31 | -$28.70M derived: sum of 3 quarters · filed 2026-04-29 | -$4.90M derived: sum of 4 quarters · filed 2026-04-29 | ||||
| 2025-03-31 | $9.60M 10-Q · filed 2026-04-29 | -$41.90M derived: sum of 2 quarters · filed 2026-04-29 | -$18.10M derived: sum of 3 quarters · filed 2026-04-29 | |||||
| 2024-12-31 | -$51.50M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-06 | -$27.70M derived: sum of 2 quarters · filed 2026-02-06 | -$27.70M 10-K · filed 2026-02-06 | |||||
| 2024-09-30 | $23.80M 10-Q · filed 2024-10-30 | $23.80M 10-Q · filed 2024-10-30 | ||||||
| 2023-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-06 | $0.00 derived: sum of 2 quarters · filed 2026-02-06 | $0.00 derived: sum of 3 quarters · filed 2026-02-06 | $0.00 10-K · filed 2026-02-06 | ||||
| 2023-09-30 | $0.00 10-Q · filed 2023-11-08 | $0.00 derived: sum of 2 quarters · filed 2023-11-08 | $0.00 10-Q · filed 2023-11-08 | $195.40M derived: sum of 4 quarters · filed 2025-02-12 | ||||
| 2023-06-30 | $0.00 10-Q · filed 2023-07-25 | $0.00 10-Q · filed 2023-07-25 | $195.40M derived: sum of 3 quarters · filed 2025-02-12 | $197.50M derived: sum of 4 quarters · filed 2025-02-12 | ||||
| 2023-03-31 | $0.00 10-Q · filed 2023-04-25 | $195.40M derived: sum of 2 quarters · filed 2025-02-12 | $197.50M derived: sum of 3 quarters · filed 2025-02-12 | $202.00M derived: sum of 4 quarters · filed 2025-02-12 | ||||
| 2022-12-31 | $195.40M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-12 | $197.50M derived: sum of 2 quarters · filed 2025-02-12 | $202.00M derived: sum of 3 quarters · filed 2025-02-12 | $209.10M 10-K · filed 2025-02-12 | ||||
| 2022-09-30 | $2.10M 10-Q · filed 2023-11-08 | $6.60M derived: sum of 2 quarters · filed 2023-11-08 | $13.70M 10-Q · filed 2023-11-08 | $15.30M derived: sum of 4 quarters · filed 2024-02-14 | ||||
| 2022-06-30 | $4.50M 10-Q · filed 2023-07-25 | $11.60M 10-Q · filed 2023-07-25 | $13.20M derived: sum of 3 quarters · filed 2024-02-14 | $28.80M derived: sum of 4 quarters · filed 2024-02-14 | ||||
| 2022-03-31 | $7.10M 10-Q · filed 2023-04-25 | $8.70M derived: sum of 2 quarters · filed 2024-02-14 | $24.30M derived: sum of 3 quarters · filed 2024-02-14 | $24.00M derived: sum of 4 quarters · filed 2024-02-14 | ||||
| 2021-12-31 | $1.60M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-14 | $17.20M derived: sum of 2 quarters · filed 2024-02-14 | $16.90M derived: sum of 3 quarters · filed 2024-02-14 | $50.70M 10-K · filed 2024-02-14 | ||||
| 2021-09-30 | $15.60M 10-Q · filed 2022-10-25 | $15.30M derived: sum of 2 quarters · filed 2022-10-25 | $49.10M 10-Q · filed 2022-10-25 | $111.90M derived: sum of 4 quarters · filed 2023-02-15 | ||||
| 2021-06-30 | -$300.00K 10-Q · filed 2022-07-20 | $33.50M 10-Q · filed 2022-07-20 | $96.30M derived: sum of 3 quarters · filed 2023-02-15 | $125.30M derived: sum of 4 quarters · filed 2023-02-15 | ||||
| 2021-03-31 | $33.80M 10-Q · filed 2022-05-03 | $96.60M derived: sum of 2 quarters · filed 2023-02-15 | $125.60M derived: sum of 3 quarters · filed 2023-02-15 | $115.60M derived: sum of 4 quarters · filed 2023-02-15 | ||||
| 2020-12-31 | $62.80M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-15 | $91.80M derived: sum of 2 quarters · filed 2023-02-15 | $81.80M derived: sum of 3 quarters · filed 2023-02-15 | $86.30M 10-K · filed 2023-02-15 | ||||
| 2020-09-30 | $29.00M 10-Q · filed 2021-10-20 | $19.00M derived: sum of 2 quarters · filed 2021-10-20 | $23.50M 10-Q · filed 2021-10-20 | $21.00M derived: sum of 4 quarters · filed 2021-10-20 | ||||
| 2020-06-30 | -$10.00M 10-Q · filed 2021-07-22 | -$5.50M 10-Q · filed 2021-07-22 | -$8.00M derived: sum of 3 quarters · filed 2021-07-22 | $49.80M derived: sum of 4 quarters · filed 2021-07-22 | ||||
| 2020-03-31 | $4.60M 10-Q · filed 2021-04-22 | $2.00M derived: sum of 2 quarters · filed 2021-04-22 | $59.80M derived: sum of 3 quarters · filed 2021-04-22 | $79.80M derived: sum of 4 quarters · filed 2021-04-22 | ||||
| 2019-12-31 | -$2.60M 10-K · filed 2020-02-06 | $55.20M derived: sum of 2 quarters · filed 2020-10-21 | $75.20M derived: sum of 3 quarters · filed 2020-10-21 | $63.70M 10-K · filed 2022-02-03 | ||||
| 2019-09-30 | $57.80M 10-Q · filed 2020-10-21 | $77.80M derived: sum of 2 quarters · filed 2020-10-21 | $66.30M 10-Q · filed 2020-10-21 | -$13.00M derived: sum of 4 quarters · filed 2020-10-21 | ||||
| 2019-06-30 | $20.00M 10-Q · filed 2020-07-22 | $8.50M 10-Q · filed 2020-07-22 | -$70.80M derived: sum of 3 quarters · filed 2020-07-22 | $17.10M derived: sum of 4 quarters · filed 2020-07-22 | ||||
| 2019-03-31 | -$11.50M 10-Q · filed 2020-04-23 | -$90.80M derived: sum of 2 quarters · filed 2020-04-23 | -$2.90M derived: sum of 3 quarters · filed 2020-04-23 | -$4.80M derived: sum of 4 quarters · filed 2020-04-23 | ||||
| 2018-12-31 | -$79.30M 10-K · filed 2020-02-06 | $8.60M derived: sum of 2 quarters · filed 2020-02-06 | $6.70M derived: sum of 3 quarters · filed 2020-02-06 | $12.30M 10-K · filed 2021-02-03 | ||||
| 2018-09-30 | $87.90M 10-K · filed 2020-02-06 | $86.00M derived: sum of 2 quarters · filed 2020-02-06 | $91.60M 10-Q · filed 2019-10-22 | $90.10M derived: sum of 4 quarters · filed 2020-02-06 | ||||
| 2018-06-30 | -$1.90M 10-K · filed 2020-02-06 | $3.70M 10-Q · filed 2019-07-24 | $2.20M derived: sum of 3 quarters · filed 2020-02-06 | -$27.80M derived: sum of 4 quarters · filed 2020-02-06 | ||||
| 2018-03-31 | $5.60M 10-K · filed 2020-02-06 | $4.10M derived: sum of 2 quarters · filed 2020-02-06 | -$25.90M derived: sum of 3 quarters · filed 2020-02-06 | -$47.10M derived: sum of 4 quarters · filed 2020-02-06 | ||||
| 2017-12-31 | -$1.50M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-06 | -$31.50M derived: sum of 2 quarters · filed 2020-02-06 | -$52.70M derived: sum of 3 quarters · filed 2020-02-06 | -$62.70M 10-K · filed 2020-02-06 | ||||
| 2017-09-30 | -$30.00M 10-Q · filed 2018-10-23 | -$51.20M derived: sum of 2 quarters · filed 2018-10-23 | -$61.20M 10-Q · filed 2018-10-23 | -$57.20M derived: sum of 4 quarters · filed 2019-02-06 | ||||
| 2017-06-30 | -$21.20M 10-Q · filed 2018-07-24 | -$31.20M 10-Q · filed 2018-07-24 | -$27.20M derived: sum of 3 quarters · filed 2019-02-06 | -$33.10M derived: sum of 4 quarters · filed 2019-02-06 | ||||
| 2017-03-31 | -$10.00M 10-Q · filed 2018-04-24 | -$6.00M derived: sum of 2 quarters · filed 2019-02-06 | -$11.90M derived: sum of 3 quarters · filed 2019-02-06 | -$22.50M derived: sum of 4 quarters · filed 2019-02-06 | ||||
| 2016-12-31 | $4.00M derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-06 | -$1.90M derived: sum of 2 quarters · filed 2019-02-06 | -$12.50M derived: sum of 3 quarters · filed 2019-02-06 | -$14.80M 10-K · filed 2019-02-06 | ||||
| 2016-09-30 | -$5.90M 10-Q · filed 2017-10-24 | -$16.50M derived: sum of 2 quarters · filed 2017-10-24 | -$18.80M 10-Q · filed 2017-10-24 | -$43.40M derived: sum of 4 quarters · filed 2018-02-01 | ||||
| 2016-06-30 | -$10.60M 10-Q · filed 2017-07-25 | -$12.90M 10-Q · filed 2017-07-25 | -$37.50M derived: sum of 3 quarters · filed 2018-02-01 | -$37.70M derived: sum of 4 quarters · filed 2018-02-01 | ||||
| 2016-03-31 | -$2.30M 10-Q · filed 2017-04-25 | -$26.90M derived: sum of 2 quarters · filed 2018-02-01 | -$27.10M derived: sum of 3 quarters · filed 2018-02-01 | -$24.90M derived: sum of 4 quarters · filed 2018-02-01 | ||||
| 2015-12-31 | -$24.60M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-01 | -$24.80M derived: sum of 2 quarters · filed 2018-02-01 | -$22.60M derived: sum of 3 quarters · filed 2018-02-01 | -$30.50M 10-K · filed 2018-02-01 | ||||
| 2015-09-30 | -$200.00K 10-Q · filed 2016-10-26 | -$244.00K 10-Q · filed 2015-10-21 | $2.00M derived: sum of 2 quarters · filed 2016-10-26 | -$5.90M 10-Q · filed 2016-10-26 | -$5.89M 10-Q · filed 2015-10-21 | -$13.11M derived: sum of 4 quarters · filed 2017-02-02 | ||
| 2015-06-30 | $2.20M 10-Q · filed 2016-07-21 | $2.20M 10-Q · filed 2015-07-24 | -$5.60M 10-Q · filed 2016-07-21 | -$5.64M 10-Q · filed 2015-07-24 | -$12.91M derived: sum of 3 quarters · filed 2017-02-02 | $36.49M derived: sum of 4 quarters · filed 2017-02-02 | ||
| 2015-03-31 | -$7.80M 10-Q · filed 2016-04-21 | -$7.84M 10-Q · filed 2015-04-24 | -$15.11M derived: sum of 2 quarters · filed 2017-02-02 | $34.29M derived: sum of 3 quarters · filed 2017-02-02 | $30.27M derived: sum of 4 quarters · filed 2017-02-02 | |||
| 2014-12-31 | -$7.31M derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-02 | $42.09M derived: sum of 2 quarters · filed 2017-02-02 | $38.07M derived: sum of 3 quarters · filed 2017-02-02 | $38.90M 10-K · filed 2017-02-02 | $38.89M 10-K · filed 2015-02-04 | |||
| 2014-09-30 | $49.40M 10-K · filed 2016-02-03 | $49.43M 10-Q · filed 2014-10-22 | $45.38M derived: sum of 2 quarters · filed 2016-02-03 | $46.21M 10-Q · filed 2015-10-21 | $43.70M derived: sum of 4 quarters · filed 2016-02-03 | |||
| 2014-06-30 | -$4.02M 10-Q · filed 2015-07-24 | -$3.22M 10-Q · filed 2015-07-24 | -$5.70M derived: sum of 3 quarters · filed 2016-02-03 | -$5.61M derived: sum of 4 quarters · filed 2016-02-03 | ||||
| 2014-03-31 | $799.00K 10-Q · filed 2015-04-24 | -$1.68M derived: sum of 2 quarters · filed 2016-02-03 | -$1.59M derived: sum of 3 quarters · filed 2016-02-03 | $3.58M derived: sum of 4 quarters · filed 2016-02-03 | ||||
| 2013-12-31 | -$2.48M derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-03 | -$2.39M derived: sum of 2 quarters · filed 2016-02-03 | $2.78M derived: sum of 3 quarters · filed 2016-02-03 | $500.00K 10-K · filed 2016-02-03 | $547.00K 10-K · filed 2014-02-06 | |||
| 2013-09-30 | $97.00K 10-Q · filed 2014-10-22 | $5.26M derived: sum of 2 quarters · filed 2014-10-22 | $2.98M 10-Q · filed 2014-10-22 | -$646.00K derived: sum of 4 quarters · filed 2015-02-04 | ||||
| 2013-06-30 | $5.16M 10-Q · filed 2014-07-23 | $2.89M 10-Q · filed 2014-07-23 | -$743.00K derived: sum of 3 quarters · filed 2015-02-04 | -$10.20M derived: sum of 4 quarters · filed 2015-02-04 | ||||
| 2013-03-31 | -$2.28M 10-Q · filed 2014-04-23 | -$5.91M derived: sum of 2 quarters · filed 2015-02-04 | -$15.36M derived: sum of 3 quarters · filed 2015-02-04 | -$28.22M derived: sum of 4 quarters · filed 2015-02-04 | ||||
| 2012-12-31 | -$3.63M derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-04 | -$13.09M derived: sum of 2 quarters · filed 2015-02-04 | -$25.94M derived: sum of 3 quarters · filed 2015-02-04 | -$27.20M 10-K · filed 2015-02-04 | ||||
| 2012-09-30 | -$9.46M 10-Q · filed 2013-10-28 | -$22.31M derived: sum of 2 quarters · filed 2013-10-28 | -$23.57M 10-Q · filed 2013-10-28 | |||||
| 2012-06-30 | -$12.86M 10-Q · filed 2013-07-25 | -$14.12M 10-Q · filed 2013-07-25 | ||||||
| 2011-12-31 | -$36.06M 10-K · filed 2014-02-06 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Revolution Medicines, Inc. (RVMD) | United States | $42.805B | -22.69 |
| EXELIXIS, INC. (EXEL) | United States | $14.358B | 16.15 |
| NEUROCRINE BIOSCIENCES INC (NBIX) | United States | $14.131B | 24.25 |
| HALOZYME THERAPEUTICS, INC. (HALO) | United States | $13.083B | 21.59 |
| Twist Bioscience Corp (TWST) | United States | $11.540B | -47.21 |
| BIO-TECHNE Corp (TECH) | United States | $11.379B | 74.68 |
| REPLIGEN CORP (RGEN) | United States | $10.755B | 185.31 |
| Krystal Biotech, Inc. (KRYS) | United States | $10.210B | 45.56 |
| Kymera Therapeutics, Inc. (KYMR) | United States | $9.631B | -31.69 |
| ImmunityBio, Inc. (IBRX) | United States | $9.157B | -9.29 |